STATE STREET CORP - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$10,890
-40.6%
52,3540.0%0.00%
Q1 2023$18,324
-17.8%
52,354
-50.0%
0.00%
Q4 2022$22,302
+23.9%
104,708
+100.0%
0.00%
Q3 2022$18,000
-74.3%
52,3540.0%0.00%
Q2 2022$70,000
-33.3%
52,3540.0%0.00%
Q1 2022$105,000
-22.2%
52,354
+4.4%
0.00%
Q4 2021$135,000
-37.2%
50,1540.0%0.00%
Q3 2021$215,000
+72.0%
50,154
+2.5%
0.00%
Q2 2021$125,00048,9540.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders